在黑色素瘤中通过自抑制提高MHC- I抗原呈现和抗瘤免疫力
He Luo1,2, Dan Chen1,2, Jing Zhou1,3
1Research Center of Integrative Medicine, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
Cells
|August 27, 2025
概括
通过提高黑色素瘤细胞中主要基因相容性复合物I类 (MHC- I) 的呈现,增强抗瘤免疫力. 这种天然化合物破坏了自,改善了CD8+T细胞的反应,并提高了免疫疗法的疗效.
科学领域:
- 免疫学
- 癌症生物学
- 药理学
背景情况:
- 大型组织相容性复合体I类 (MHC- I) 通过CD8+T细胞识别对抗瘤免疫具有至关重要的作用.
- 通过调节MHC- I通路,可以提高黑色素瘤免疫疗法的有效性.
研究的目的:
- 为了研究Cepharanthine (CEP) 在黑色素瘤中的抗瘤活性.
- 阐明CEP增强抗瘤免疫力的机制,重点关注MHC-I表现和自.
主要方法:
- 用CEP和巴菲洛米辛A1治疗黑色素瘤细胞.
- 评估MHC-I表达水平 (膜结合和总量).
- 使用GFP-LC3点和光成像进行自流分析,以评估溶酶体酸化和自体-溶酶体融合.
主要成果:
- 治疗CEP会以剂量依赖的方式增加黑色素瘤细胞的MHC- I表达.
- CEP对MHC- I的影响与自失调有关,特别是通过损害 lysosomal 酸化来抑制晚期自流.
- CEP促进了CD8+T细胞的透,并增强了抗PD-1疗法的疗效,从而导致优异的瘤抑制.
结论:
- 通过选择性溶解体抑制来增强MHC- I呈现的作用.
- CEP创造了一个更容易受到免疫监测的瘤微环境,改善了抗瘤反应.
- 在黑色素瘤中,CEP是提高免疫检查点阻塞治疗结果的潜在策略.
相关概念视频
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Antigen Processing Pathways
1.3K
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
MHC Class I: Presenting Endogenous...
1.3K
Autophagy
4.6K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.6K
Antigens Involved in Adaptive Immunity
667
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
667
Cytotoxic T Cells-mediated Immune Response
1.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K


